S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors

LESSONS LEARNED: Despite having significant rationale, S0502 failed to accrue for a number of reasons. Vetting a trial first, with scientific experts and funding agencies, does not guarantee success, especially when dealing with a rare tumor and/or one with an existing highly effective therapy. In t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Blanke, Charles D., Rankin, Cathy, Corless, Christopher, Eary, Janet F., Mulder, Karen, Okuno, Scott H., George, Suzanne, Heinrich, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679092/
https://ncbi.nlm.nih.gov/pubmed/26576593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0295
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados